We performed western blot analysis and immunohistochemistry, and found that SLC7A11 and GPX4 protein expression were reduced in HCC cells and the GSH/GSSG ratio was decreased after PZH treatment. The gene discussed is GPX4; the disease is hepatocellular carcinoma.